Eprazinone Hydrochloride
盐酸依普拉酮
Report date: 2023/02/27 17:44:29
NME
Base Information
Drug NameEprazinone Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1974/02/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesTaiyo Co LtdGuangzhou Maite Xinghua Drug Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A